SightMD Announces Acquisition of Park Avenue Eye Institute and Robert R. Ditkoff, M.D.

Monday, July 29, 2019 General News
Email Print This Page Comment bookmark
Font : A-A+

SightMD (or the "Company"), a leading multi-specialty ophthalmology platform and a portfolio company of Chicago Pacific Founders, today announced a strategic partnership with Robert R. Ditkoff, M.D., P.C., d/b/a Park Avenue Eye Institute, a Manhattan-based ophthalmology practice. Park Avenue Eye Institute represents SightMD's second office in Manhattan, with its leading provider, Dr. Ditkoff, bringing over 30 years of ophthalmic experience to SightMD's growing team of over 70 providers and 33 convenient locations spanning Westchester County through New York City and Long Island.

HAUPPAUGE, N.Y., July 29, 2019 /PRNewswire-PRWeb/ -- SightMD (or the "Company"), a leading multi-specialty ophthalmology

platform and a portfolio company of Chicago Pacific Founders, today announced a strategic partnership with Robert R. Ditkoff, M.D., P.C., d/b/a Park Avenue Eye Institute, a Manhattan-based ophthalmology practice. Park Avenue Eye Institute represents SightMD's second office in Manhattan, with its leading provider, Dr. Ditkoff, bringing over 30 years of ophthalmic experience to SightMD's growing team of over 70 providers and 33 convenient locations spanning Westchester County through New York City and Long Island.

Dr. Ditkoff is a native New Yorker who has spent the entirety of his medical career providing ophthalmic and refractive services through Park Avenue Eye Institute on the Upper East Side of Manhattan. He attended medical school at Boston University in the esteemed six-year medical program and trained at the Mount Sinai Hospital in New York City. Today, Dr. Ditkoff is affiliated with Mount Sinai Hospital, The Manhattan Eye, Ear and Throat Hospital and Lenox Hill Hospital. Dr. Ditkoff is an assistant clinical professor at the Mount Sinai Icahn School of Medicine.

"My partners and I are excited to welcome Dr. Ditkoff to the SightMD family," said Jeffrey Martin, MD, a Co-Founder and President of SightMD. "Dr. Ditkoff's commitment to clinical excellence and improving the lives of his patients make him a seamless fit with our practice and providers. We look forward to helping Dr. Ditkoff grow his practice, and to expanding SightMD's presence in Manhattan."

Dr. Ditkoff added, "SightMD's physician-led, patient-centric culture and history of serving New York were paramount in determining that SightMD was the right choice for me, my staff and, most importantly, my patients. I found the SightMD team to be transparent and collaborative throughout the transaction process, and could not be more thrilled to be partnering with such a stellar organization."

Dr. Ditkoff will maintain his existing schedule pursuant to this partnership. SightMD's strategic partnership with Dr. Ditkoff represents the eighth practice to join the Company since it partnered with Chicago Pacific Founders in September 2018.

About SightMD SightMD is a rapidly-growing integrated ophthalmic provider group, offering patients access to over 50 ophthalmic surgeons and specialists through the convenience of 33 locations spanning the east end of Long Island, Westchester County and Manhattan. SightMD's track record of providing clinically-excellent care spans over 50 years, and its services include laser cataract surgery and lens implantation, glaucoma management, retinal disorder treatment, corneal services, neuro-ophthalmology, LASIK laser vision correction, oculoplastic surgery, pediatric ophthalmology, and audiology. SightMD provides its physicians with world-class management services, including a 24/7 call center, billing, credentialing, human resources and other services, enabling them to continue delivering best-in-class care to patients in SightMD's community. SightMD is backed by Chicago Pacific Founders, a leading middle market private equity firm which focuses exclusively on partnerships with growing companies in the healthcare services sector. For more information about SightMD, please visit http://www.sightmd.com

 

SOURCE SightMD



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store